China's CAMS publishes first national neuroethics guidelines for BCI research
Summary
The Chinese Academy of Medical Sciences published China's first national guidelines for neuroethics in BCI research, covering informed consent, data privacy, cognitive liberty, and equitable access. The 48-page document aligns with WHO neurorights principles while emphasizing Chinese regulatory specifics and applies to all BCI research conducted in mainland China from 2025.
Why it matters
China's domestic neuroethics framework is an essential prerequisite for responsible scaling of their BCI research programme. Alignment with WHO neurorights principles signals China's intent to participate in international neurotech governance — important context for understanding how Chinese BCI products will be regulated globally.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial